EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term prognostic value of cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy

Leopoldo Ordine iD, Grazia Canciello, Salvatore Di Napoli, Roberto Polizzi, Daniela Pacella, Raffaella Lombardi, Giovanni Esposito, Maria-Angela Losi

ESC Heart Failure · 2026

DOI: 10.1093/eschf/xvag013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2026. Verfasst von Leopoldo Ordine und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Biomedical Sciences, University of Naples 'Federico II', School of Medicine, Via S Pansini, 5, Naples I-80131, Italy. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Exercise Test. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypertrophic cardiomyopathy (HCM) is a heterogeneous myocardial disorder characterized by left ventricular hypertrophy. The role of cardiopulmonary exercise testing (CPET) in predicting major adverse cardiac events (MACE) remains incompletely understood, particularly over long-term follow-up and independently of baseline symptoms.

Methods

We longitudinally studied 154 HCM patients (age 43 ± 16 years; 27% female), who underwent symptom-limited CPET. At baseline, 98 patients were in New York Heart Association (NYHA) Class I, 48 in Class II, and 8 in Class III. Septal reduction therapies (SRT), progression to end-stage HCM (ES-HCM), sudden cardiac death (SCD), heart failure-related death (HF), and heart transplantation (HT) represented a composite MACE endpoint.

Results

Over a mean follow-up of 12 ± 9 years, 38 patients experienced MACE (SRT = 9; ES-HCM = 11; SCD = 10; HF/HT = 8). In multivariable analysis, independent predictors of MACE were percentage predicted peak VO2 (PVO2%) < 60 [hazard ratio (HR) 4.16, 95% confidence interval (CI) 1.89–9.14; P < .001], and NYHA Class >I (HR 2.27, 95% CI 1.06–4.89; P = .036). By using SRT as a competing risk, the only predictor of MACE became PVO2% < 60 (HR 3.966, 95% CI 1.626–9.670; P = .002). Among asymptomatic patients (i.e. NYHA Class I), only PVO2% < 60 remained a significant predictor of MACE (HR 5.611, 95% CI 1.635–19.253; P = .006), with risk divergence evident after nearly 15 years of follow-up. The result was also confirmed in the competing risk analysis.

Conclusion

In this long follow-up study, CPET is a powerful prognostic tool in HCM. A reduced peak VO2 identifies those at higher risk, highlighting the potential for CPET to improve risk stratification, even among patients classified as NYHA Class I.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicExercise TestHumansFemalePrognosisMaleAdultFollow-Up StudiesMiddle AgedTime FactorsLongitudinal StudiesDeath, Sudden, CardiacDisease ProgressionOxygen Consumption

Stichwörter der Autor:innen

Cardiopulmonary exercise testingExercise capacityHeart failureHypertrophic cardiomyopathyPreventive cardiologyPrognosis

Autor:innen und Institutionen

  • Department of Advanced Biomedical Sciences, University of Naples 'Federico II', School of Medicine, Via S Pansini, 5, Naples I-80131, Italy.
  • Department of Public Health, University of Naples 'Federico II', School of Medicine, Via S Pansini, 5, Naples I-80131, Italy.

ORCID-Profile: Leopoldo Ordine

Zitieren

APA

Ordine, L., Canciello, G., Di Napoli, S., Polizzi, R., Pacella, D., Lombardi, R., Esposito, G., & Losi, M. A. (2026). Long-term prognostic value of cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag013

Vancouver

Ordine L, Canciello G, Di Napoli S, Polizzi R, Pacella D, Lombardi R, et al. Long-term prognostic value of cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy. ESC Heart Failure. 2026. doi:10.1093/eschf/xvag013

BibTeX
@article{Ordine2026,
  author = {Ordine, Leopoldo and Canciello, Grazia and Di Napoli, Salvatore and Polizzi, Roberto and Pacella, Daniela and Lombardi, Raffaella and Esposito, Giovanni and Losi, Maria-Angela},
  title = {Long-term prognostic value of cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy},
  journal = {ESC Heart Failure},
  year = {2026},
  doi = {10.1093/eschf/xvag013}
}
Kostenlos starten →